1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Ertugliflozin
Trade Name:
Steglatro
Manufacturer/Distributor:
Merck Canada
merck.ca
Classification:
Sodium-glucose co-transporter 2 (SGLT2) inhibitor
Antidiabetic agent
ATC Class:
A10BK04 - ertugliflozin
Status:
active
Notice of Compliance (yyyy/mm/dd):
2018/05/09
Date Marketed in Canada (yyyy/mm/dd):
2018/05/23
Presentation:
Tablet: 5 mg. DIN:02475510
Tablet: 15 mg. DIN: 02475529
Comments:
For use as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus for whom metformin is inappropriate due to contraindications or intolerance.
Back to:
Drug Product Listings 
